FCGR2A and myeloid sarcoma: Furthermore, histopathologic studies have shown that Ig deposition and increased microglial FcγR immunoreactivity characterizes active demyelinating lesions [23, 24], raising the possibility that IgG autoantibodies in the brains of people with MS may induce damaging microglial inflammation via FcγR activation.